AIM: To assess morbidity, mortality and cancer-related outcomes after supervised rectal resection for cancer by surgical specialist registrars (SpRs). PATIENTS: A total of 205 consecutive patients (115 male; median age 64 years [range, 24-90 years]) under the care of six consultant surgeons, who underwent elective rectal resection of their rectal cancer between 1995-1999 were studied. The modified Dukes' stages were A in 28 patients (13%), B in 47 (21%), C in 103 (51%), and D in 30 (15%). RESULTS: Sixty-eight patients (35 males) of mean age 64 years (range, 38-82 years) underwent supervised resection (60 anterior resections. 8 abdomino-perineal resections) by a SpR. Of these, 7 (10%) were modified Dukes' stage A, 16 (22%) stage B, 37 (54%) stage C, and 8 (13%) stage D. Postoperative morbidity (SpRs 32% versus consultants 41%; P = 0.25) and mortality (SpRs 3% versus consultants 6%; P = 0.1) were comparable with consultant outcomes. Local recurrence rates (SpRs 9% versus consultants 9%; P = 0.5) and crude survival (SpRs 64% versus consultants 61%; P = 0.31) were also comparable after a median follow-up of 48 months (range, 24-72 months). CONCLUSION: Operative and cancer-related outcomes are not compromised by supervised SpR resections of rectal cancer in selected patients.
展开▼
机译：目的：评估由外科专科医生进行的直肠直肠癌切除术后的发病率，死亡率和与癌症相关的结局。患者：总共205例患者（115例男性，中位年龄64岁[范围，24-90岁]）在6位顾问外科医生的护理下进行了研究，他们在1995-1999年间接受了直肠癌的选择性直肠切除术。改良后的Dukes分期为：A患者28例（13％），B患者47例（21％），C患者103例（51％），D患者30例（15％）。结果：平均年龄64岁（范围38-82岁）的68例患者（35例男性）接受了SpR监督性切除（60例前切除，8例腹－会阴切除）。在这些患者中，有7（10％）属于Dukes改良期A期，16（22％）B期，37（54％）C期和8（13％）D期。术后发病率（SpRs 32％，咨询师41％ ； P = 0.25）和死亡率（SpRs为3％，顾问为6％； P = 0.1）与顾问的结果相当。在中位随访48个月（范围24-72）后，局部复发率（SpRs 9％，顾问9％； P = 0.5）和原始生存率（SpRs 64％，顾问61％； P = 0.31）也可比。个月）。结论：在选定患者中，经监督的直肠癌SpR切除术不会损害手术和与癌症相关的结果。
展开▼
